Biotechnology Medicare’s Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more